Jeremy Warner Archives
Convalescent plasma improved survival in COVID-19 patients with blood cancers
Feb. 5, 2021—Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).
Initiative seeks to extract cancer phenotypes from electronic health records
Oct. 15, 2020—The National Cancer Institute (NCI) has funded the development of interactive visual tools that will allow researchers to extract cancer phenotypes from electronic medical records.
New data offer insights on COVID treatments for people with cancer
Jul. 22, 2020—Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population.
Multinational consortium reports COVID-19 impact on cancer patients
May. 28, 2020—People with cancer sickened by COVID-19 have a crude death rate of 13%, according to the largest series of data released thus far from a multinational perspective. The data on more than 900 patients, published May 28 in The Lancet and simultaneously presented at ASCO20 Virtual, also revealed cancer-specific factors associated with increased mortality.
Initiative to explore COVID-19 outcomes in cancer patients
Apr. 30, 2020—A multi-institutional consortium led by Vanderbilt-Ingram Cancer Center (VICC) is collecting data on cancer patients with COVID-19 as part of a rapid effort to understand the unique effects the coronavirus has on this vulnerable population.
Grant to help address complexity of cancer care
Jan. 10, 2019—Jeremy Warner, MD, MS, associate professor of Medicine and Biomedical Informatics, has been awarded a $1 million grant from the National Cancer Institute to develop software that will help clinicians keep up with the increasing complexity of cancer care.
Seven named as fellows of Medical Informatics Association
Dec. 20, 2018—Seven Vanderbilt University Medical Center employees are among an inaugural group of 130 fellows of the American Medical Informatics Association (AMIA).
Warner’s medical informatics research recognized
Nov. 1, 2018—Jeremy Warner, MD, is the 2018 recipient of the New Investigator Award from the American Medical Informatics Association (AMIA).
Report identifies IT upgrades needed to enhance cancer care
Aug. 17, 2017—A group of nationally recognized medical information and data management experts has recommended the development of new knowledge software applications that work alongside electronic health record systems (EHRs) to help practicing oncologists access and use the latest genomic information to assist in the treatment of cancer patients.
Children at risk for complications from brown recluse spider bites: study
Apr. 27, 2017—Medical complications of brown recluse spider bites are uncommon but they can be severe, particularly in children, researchers at Vanderbilt University Medical Center (VUMC) reported April 19.
New software tracks cancer mutations, survival
Jun. 2, 2016—A team at Vanderbilt University Medical Center (VUMC) has developed and tested software that scans electronic health records in real time to monitor cancer patient survival (from time of diagnosis) according to which genes, if any, are found to carry mutations.
Warner named medical director of Cancer Registry
Feb. 11, 2016—Jeremy Warner, M.D., M.S., assistant professor of Medicine and Biomedical Informatics, has been named medical director of the Vanderbilt Cancer Registry at Vanderbilt-Ingram Cancer Center (VICC).
